Accuracy of migraine diagnosis and treatment by neurologists in the Baltic states : e-survey with clinical case challenge

dc.contributor.authorJokubaitis, Mantas
dc.contributor.authorVrublevska, Greta
dc.contributor.authorZvaune, Linda
dc.contributor.authorBraschinsky, Mark
dc.contributor.authorLeheste, Alo Rainer
dc.contributor.authorSaknītis, Gatis
dc.contributor.authorŽukovs, Danils
dc.contributor.authorRyliškienė, Kristina
dc.date.accessioned2024-02-23T20:15:02Z
dc.date.available2024-02-23T20:15:02Z
dc.date.issued2023-12
dc.descriptionPublisher Copyright: © 2023, The Author(s).
dc.description.abstractBackground: Underdiagnosis of migraine causes a significant health burden, including lower quality of life, excessive medication use, and a delay in effective treatment. The purpose of this study was to evaluate migraine diagnosis accuracy and to review the treatment approaches used by neurologists in the Baltic states. Methods: The research was conducted as an anonymous e-survey with four cases in March and April 2021. Results: 119 practicing adult neurologists have participated. The migraine diagnostic accuracy was 63.2%. The most commonly used diagnostic criteria were moderate/severe pain, unilateral pain, and disruption of daily activities. Diagnostic accuracy did not differ significantly between neurologists who always use ICHD-3 criteria and those who don’t (68.4% vs. 58.5%, p = 0.167). It was higher in neurologists who were working in headache centers (91.7% vs. 60.9%, p = 0.012), and was related to a higher percentage of migraine diagnoses in all consulted headache patients (R 2 = 0.202, adjusted R 2 = 0.195, p < 0.001), prophylaxis with onabotulinumtoxin A [OR = 4.332, 95% Cl (1.588–11.814)], and anti-CGRP monoclonal antibodies [OR = 2.862, 95% Cl (1.186–6.907)]. Conclusions: Migraine diagnostic accuracy is improved through practical patient counseling and modern treatment prescription. Although the neurologists in the Baltic states follow current European guidelines, there is room for improvement in diagnostic accuracy to reduce migraine burden.en
dc.description.statusPeer reviewed
dc.format.extent9
dc.format.extent781213
dc.identifier.citationJokubaitis, M, Vrublevska, G, Zvaune, L, Braschinsky, M, Leheste, A R, Saknītis, G, Žukovs, D & Ryliškienė, K 2023, 'Accuracy of migraine diagnosis and treatment by neurologists in the Baltic states : e-survey with clinical case challenge', European Journal of Medical Research, vol. 28, no. 1, 600. https://doi.org/10.1186/s40001-023-01555-z
dc.identifier.doi10.1186/s40001-023-01555-z
dc.identifier.issn0949-2321
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/15324
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85180234918&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Medical Research
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAccuracy
dc.subjectAnti-CGRP
dc.subjectBurden
dc.subjectDiagnosis
dc.subjectMigraine
dc.subjectProphylaxis
dc.subjectTreatment
dc.subjectTriptans
dc.subject3.2 Clinical medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectGeneral Medicine
dc.titleAccuracy of migraine diagnosis and treatment by neurologists in the Baltic states : e-survey with clinical case challengeen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Accuracy_of_migraine_diagnosis_and_treatment.pdf
Size:
762.9 KB
Format:
Adobe Portable Document Format